Elucidating novel immune profiles for predicting infection in high‐risk cohorts: a pilot study in patients with relapsed and refractory chronic lymphocytic leukaemia
The combination of protein and RNA analysis can provide further insight into the interactions of immunotherapies and immunity but should be validated further in large cohorts.
Authors
- Marcel Doerflinger (ORCID: https://orcid.org/0000-0001-9159-3021)
- Monica A. Slavin (ORCID: https://orcid.org/0000-0002-8443-314X)
- Constantine Si Lun Tam (ORCID: https://orcid.org/0000-0002-9759-5017)
- Alex Garnham
- Ashley Whitechurch (ORCID: https://orcid.org/0000-0003-1635-5562)
- Connie S.N. Li Wai Suen (ORCID: https://orcid.org/0000-0003-0529-0804)
- Benjamin W. Teh (ORCID: https://orcid.org/0000-0003-0213-5470)
- Stefanie M. Bader (ORCID: https://orcid.org/0000-0002-7901-9833)
- L.J. Williams (ORCID: https://orcid.org/0009-0002-4066-3899)
Institutions
- The Royal Melbourne Hospital (AU)
- The University of Melbourne (AU)
- Walter and Eliza Hall Institute of Medical Research (AU)
- Peter MacCallum Cancer Centre (AU)
- The Alfred Hospital (AU)
- Monash University (AU)
Publication Details
- Journal
- Clinical & Translational Immunology
- Published
- 2025-01-01
- DOI
- https://doi.org/10.1002/cti2.70049
- Primary Topic
- Chronic Lymphocytic Leukemia Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- University of Melbourne
- National Health and Medical Research Council